Eisai to launch medication administration support device e-okusuri-sanx





Eisai Co., Ltd. has announced that the medication administration support device e-OKUSURI-SAN® will be launched today for sale to pharmacies,

medical institutions and caregiving facilities in Japan. This device supports treatment administration for patients, families, pharmacists, nurses and caregivers, by ensuring that the prescribed dosage of medicine is administered at the scheduled time, thus helping to prevent patients from forgetting to take medicine or overdosing.

The device is also equipped with a function to support looking after patients by allowing those concerned, including family and pharmacists, to remotely confirm a patient's record of medicine administration via an exclusive cloud website system.

A week's worth of medicine cases can be set in e-OKUSURI-SAN, with up to four doses scheduled for each day (morning, middle of the day, night and before bed). At the scheduled time, a medicine case slides out, along with audio and visual prompts reminding the patient to take the medicine. The device comes with four different voices to choose from, as well as the option to record a custom voice such as a grandchild's. If the medicine case is not taken, in addition to a snooze function to replay the audio prompt, the medicine case will be retracted after 40 minutes. As a general rule, the medicine case cannot be retrieved until the next scheduled administration time, to prevent patients from overdosing.

As a function to support looking after patients, e-OKUSURI-SAN can send an email to family members, pharmacists, nurses or caregivers when medicines are administered. Medication administration history is stored for up to a year on an exclusive website on the cloud, with an option to view monthly line graphs or tables based on the data. This allows those concerned, including family and pharmacists, to notice any breakdowns in lifestyle patterns, even from a remote location.

Ahead of the launch, approximately 100 pharmacies, medical institutions and care facilities throughout the country cooperated to conduct a demonstration study using test units for home treatment and at facilities. As a result, various observations were made, including an increase in administration rates, supporting prevention of overdosing, and a reduction in the burden on families, pharmacists and caregivers to support patients. Furthermore, there were cases of patients being able to maintain an appropriate lifestyle routine by using the device, as well as cases of families noticing a breakdown in lifestyle rhythm through the support functions, which lead to visits to medical institutions.

Through the provision of various solutions that leverage assets built up through community building activities as well as cooperation with stakeholders including medical institutions, pharmacies and care facilities, Eisai seeks to make continued contributions to address the diverse needs of, as well as increasing the benefits provided to, patients and their families.

Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120